MOLECULAR DETECTION OF SOME VIRULENCE GENE IN Proteus Mirabilis ISOLATED FROM URINARY TRACT INFECTION IN IRAQ
DOI:
https://doi.org/10.36103/ijas.v54i3.1751Keywords:
Api20E, PCR, the gene s(rsbA and luxS), sensitivity test.Abstract
This study was concentrated for isolation and identification of 60 (35.2%) Proteus mirabilis isolates out of 170 urine samples from patients suffering from urinary tract infection from different hospitals in Baghdad city during a period from September 2020 to January 2021. The isolates were cultivated on selective media and biochemical reactions were used to identify them confirmatory APi 20 E tests. The sixty selected isolates were tested for resistance against four antibiotics. The results shown that there were differences in the antibiotic resistance of isolates. High resistance to nalidixic acid and ampicillin were found among isolates as (75%) and (51%) respectively while the resistance of Proteus mirabilis isolates to amikacin and impenem, were(8.3%). Some important virulence factor to Proteus mirabilis was detected by using molecular techniques include PCR and it was found that only 18 (60%) of isolates gave positive result for rsbA at 467 bp. 27 (90%) of them gave positive result for luxS at 464 bp.
References
-Abbas, K. F., Jawad, K., Khafaji, A. L., Maysaa, S., and Shukri, A. L. 2015. Molecular detection of some virulence genes in Proteus mirabilis isolated from Hillaprovince. Intternational Journal Study in Bioscience(IJRSB), 3(10), 85-89
-Adeolu, M.; S. Alnajar,; S. Naushad, and R . S. Gupta, 2016. Genomebased phylogeny and taxonomy of the ‘Enterobacteriales’: proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov. International Journal of Ssystematic and Evolutionary Microbiology, 66:5575– 5599
-AL-Jumaa, M. H. J. 2011. Bacteriological and Molecular Study of some Isolates of Proteus mirabilis and Proteus vulgaris in Hilla Province. M.Sc. Thesis. University of Babylon.
-Badi, S. A., J., Nowroozi, and A. A. Sepahi, 2014. Detection luxS, qseC and rsbA genes' band in Proteus mirabilis and Escherichia coli isolated from urinary tract infections. Pajoohandehjournal.19(3):142-147
-Baldo, C. and S. P. D. Rocha 2014. Virulence factors of uropathogenicProteus mirabilis. International Journal of Scientific and Technology Research.3(11):24-27.
-Debnath, I., A. M.,Stringer, S. N., Smith, E., Bae, H. L., Mobley, J. T.,Wade, and M. M. Pearson, 2018. MrpJ directly regulates Proteus mirabilis virulence factors, including fimbriae and type VI secretion, during urinary tract infection. Infection and Immunity, 86(10), e00388-18
-Dharmadhikari, S.M., and A.S. Peshwe. 2009. Molecular level studies on multiple antibiotic and serum resistance in UTI pathogens. Indian J. Biotechnol. 8:40-50
-Ebringer, A., and T. Rashid, 2009. Rheumatoid arthritis is caused by Proteus: The molecular mimicry theory and karl popper. Frontiers in Bioscience.1:577-586.
-Forbes, B. A., F. S. Daniel, and S. W. Alice, 2007. Baily and scotťs diagnostic microbiology.12thed. Mosby, USA.
-Fusco, A.; L.; Coretti, V.; Savio, E.; Buommino, F.; Lembo, and G. Donnarumma, 2017. Biofilm Formation and Immunomodulatory Activity of Proteus mirabilis Clinically Isolated Strains. International Journal of Molecular Sciences, 18(2), 414.
-Girlich, D., R. A., Bonnin, L., Dortet, and T. Naas, 2020. genetics of acquired antibiotic resistance genes in. Proteus spp.
-Harley, J. P. and L. M. Prescott 2002.Laboratory Exercises in microbiolgy, 5th. ed. McGraw Hill Companies, London
-Hussein, S. 2016. Biochemical and genetic study of virulence factor hemolysin of Proteus mirabilis isolated from urinary tract infection
-Jansen, A. M.; V.; Lockatell, D. E., Johnson, and H. L. Mobley 2003. Visualization of Proteus Mirabilis morpho types in the urinary tract: the elongated swarmer cell is rarely observed in ascending urinary tract infection. Infection and Immunity.71 (6): 3607-3613.
-Liaw S. J., H. C.Lai, and W. B. Wang, 2004. Modulation of swarming and virulence by fatty acids through the rsbA Protein in Proteus mirabilis Infection and immunity, Dec. 72(12): 6836–6845.
-Ling, I.M., A.W. Lam, E.W. Chan, and A.F. Cheng. 2003.What have we learnt from community –acquired infections in Hong Kong? Journal Antimicro. Agents Chemother. 51:895-904
-Luzzaro, F., G. Lombardi, M. Perlli, R. Belloni, G. Amicosante, and A.Toniolo. 2001. Antimicrobial susceptibility testing and ESBL production in clinical isolates of Proteus mirabilis: An evaluation with the phoenix™ automated microbiology system. Presesnted at the 10 1st General Meeting of the American Society for Microbiology
-MacFaddin.2000.Biochemical tests for identification of medical bacteria. Lippincott Williams and Wilkins, USA.=19-Manos, J. and Belas, R. 2006. The genera Proteus, Providencia, and Morganella. Prokaryotes. 6:245–269
-Mordi, R.M.; and M.I. Momoh. 2009. Incidence of Proteus species in wound infections and their sensitivity pattern in the university of Benin teaching hospital. Afr. J. Biotechnol. 8 (5): 725-730
-Morgenstein, R. M. B. Szostek, and P. N. Rather, Regulation of gene expression during swarmer cell differentiation in Proteus mirabilis, FEMS Microbiology Reviews, vol. 34, no. 5, pp. 753–763, 2010
-Nielubowicz G. R, and H. L. Mobley, 2010. Host-pathogen interactions in urinary tract infection. Nature Reviews Urology.7:430–41
-Ohtani, K., H. Hayashi, and T.Shimizu, 2002. The luxS gene is involved in cell–cell signalling for toxin production in Clostridium perfringens Molecular Microbiology. 44(1): 171–179.
-Sahal, G., and Bilkay, I. S. 2015. Multidrug resistance by biofilm-forming clinical strains of Proteus mirabilis. Asian Biomedicine, 9(4), 535-554
-Sahm, D.F., C. Thornsberry, D.C.Mayfield, M.E. Jones, and J.A. Karlowsky. 2001. Multi -drug resistance urinary tract isolates of Escherichia coli: Prevalence and patient demographics in the United state in 2000. Journal Antimicrob. Agents Chemother., 45:1402- 1406
-Schaffer, J. N.; and M. M. Pearson, 2015. Proteus mirabilis and urinary tract infections. Microbiology spectrum, 3(5).
-Stepanović, S., D., Vuković, V., Hola, G. D., Bonaventura, S., Djukić, I., Ćirković, and F. Ruzicka, 2007. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by Staphylococci. Apmis, 115(8), 891-899
-Unachukwu, C. N.; Obunge, O. K. and O. J. Odia, 2005. The bacteriological of diabetic ulcer in port harcourt, Niger. Journal Medical 14(2):173-176.
-Wasfi, R.; Hamed, S. M.; Abd Allah, M. A. W. and Ismail, L. 2020. Proteus mirabilis biofilm: Development and therapeutic strategies. Frontiers in cellular and Infection Microbiology, 10, 414
-Yong Wang and Xiaoling Pan, 2014. Bacteria: Proteus, Editor(s): Yasmine Motarjemi, Encyclopedia of Food Safety, Academic Press, Pages 486-489
-Zhanel, G.G., J.A. Karlowsky, G.K.M. Harding, A. Carrle, T. Mazzullit, and D.E.A. Low. 2000. A Canadian national surveillance study of urinary tract isolates from outpatients: Comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. Journal Antimicrob. Agents Chemother. 44(4): 1089–1092.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
2.jpg)
2.jpg)
